Skip to content
cccskills
FreePublished on GitHub

endo-assess-emergency-supplies

Assesses whether the patient has emergency supplies such as glucagon, ketone strips, and backup insulin readily available. Triggered when clinicians verify the patient carries a glucagon kit or ensure backup insulin and supplies are accessible.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.4 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Assess emergency supplies availability

STEP 1 — Gather Information

Document the patient’s current emergency supplies: glucagon kit (or nasal glucagon), ketone strips, backup insulin (vials/pens), syringe or pen needles, pump infusion sets/reservoirs, and expiration dates. Ask about storage conditions and whether the patient knows how to administer glucagon.

STEP 2 — Rule In / Rule Out

If glucagon (kit or nasal) AND backup insulin are present and not expired, proceed to classification; otherwise, flag missing or expired supplies and move to address deficiencies.

STEP 3 — Classify or Stratify

Categorize emergency supply adequacy: Adequate (≥2 of glucagon, ketone strips, backup insulin), Partial (1 item present), or None (0 items present).

STEP 4 — Decide

  • Adequate: Reinforce education on storage and use; document plan.
  • Partial: Provide missing items, educate on their use, and update back‑up plan.
  • None: Arrange immediate provision of glucagon, ketone strips, and backup insulin; train patient/caregiver on administration; establish a clear back‑up plan for pump failure.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on patient self‑report without verifying expiration dates and storage conditions. Do not assume the patient knows how to mix or administer glucagon without demonstration. Do not overlook the need for ketone strips in pump users at risk for DKA. Avoid prescribing backup insulin without confirming the patient has appropriate syringes or pens.

Concrete Clinical Example

A 24‑year‑old on CSII reports having a glucagon kit but is unsure of the expiration date. Assessment reveals the kit expired 8 months ago and ketone strips are missing. The clinician provides a new glucagon kit, ketone strips, and backup insulin, demonstrates glucagon administration, and documents a back‑up plan for pump failure.

Source: Diabetes Technology—Continuous Subcutaneous Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2534

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill